ssl4.eir-parts.net/doc/2160/tdnet/2209413/00.pdf

Latest saved version

株式会社ジーエヌアイグループ 2022年12月期 第3四半期決算訂正

This is the newest public snapshot for this URL and the best place to start reviewing the page.

Source URL

https://ssl4.eir-parts.net/doc/2160/tdnet/2209413/00.pdf

About this page

This document is a notification regarding corrections to the 'Q3 Consolidated Financial Summary for the Fiscal Year Ending December 2022' released by GNI Group Inc. on November 16, 2022. The corrections are noted on pages 7, 11, and 16, with the amended content highlighted in red. Additionally, the document includes information about the company's business operations, market environment, and future outlook. GNI Group Inc. is a global healthcare company engaged in drug discovery and pharmaceutical development, operating in the United States and China.